Thomas B J, Kovatch R M, Lijinsky W
NCI-Frederick Cancer Research Facility, BRI-Basic Research Program, MD 21701.
Jpn J Cancer Res. 1988 Mar;79(3):309-13. doi: 10.1111/j.1349-7006.1988.tb01592.x.
Three nitrosamines, metabolically related and formed in vivo from the bladder carcinogen nitrosomethyl-n-octylamine, were administered to groups of 12 female F344 rats by intraurethral instillation twice a week for 30 weeks. All three compounds induced tumors in the urinary bladder. Nitrosomethyl-2-oxopropylamine at 10 mg/ml was the most potent, causing death of half of the animals with tumors at 43 weeks, following a total dose of 1.0 mmol; most of the rats also had tumors of the nasal mucosa, and there were some tumors of the kidney and kidney pelvis. Nitrosomethyl-2-hydroxypropylamine at 10 mg/ml (total dose 1.0 mmol) was much less effective, the median week of death being 83 weeks. In addition to bladder tumors, this group had tumors of the nasal mucosa, esophagus, and kidney. Nitrosomethyl-3-carboxypropylamine at 75 mg/ml and a total dose of 6.2 mmol per rat induced a high incidence of bladder tumors and tumors of the kidney pelvis, but not tumors of the nasal mucosa; the median week of death for this group was 55 weeks. It is concluded that nitrosomethyl-n-alkylamines that induce bladder tumors by oral administration to rats are metabolized to nitrosomethyl-3-carboxypropylamine, which is excreted in the urine and further metabolized to nitrosomethyl-2-oxopropylamine, the proximate bladder carcinogen.
三种亚硝胺在代谢上相互关联,由膀胱致癌物亚硝基甲基正辛胺在体内形成,每周两次经尿道滴注给予12只雌性F344大鼠,持续30周。所有这三种化合物均在膀胱诱发肿瘤。10mg/ml的亚硝基甲基-2-氧代丙胺效力最强,在总剂量达1.0mmol后,43周时半数患肿瘤动物死亡;大多数大鼠还患有鼻黏膜肿瘤,以及一些肾和肾盂肿瘤。10mg/ml的亚硝基甲基-2-羟丙胺(总剂量1.0mmol)效果则差得多,死亡中位周数为83周。除膀胱肿瘤外,该组大鼠还患有鼻黏膜、食管和肾肿瘤。75mg/ml的亚硝基甲基-3-羧基丙胺,每只大鼠总剂量为6.2mmol,诱发膀胱肿瘤和肾盂肿瘤的发生率很高,但未诱发鼻黏膜肿瘤;该组死亡中位周数为55周。得出的结论是,经口给予大鼠可诱发膀胱肿瘤的亚硝基甲基-n-烷基胺代谢为亚硝基甲基-3-羧基丙胺,其经尿液排泄并进一步代谢为亚硝基甲基-2-氧代丙胺,即直接的膀胱致癌物。